TOT BIOPHARM’s 16,000L-capacity monoclonal antibodies production base put into operation
Improving the quality of life for cancer patients worldwide with innovative science and technology SUZHOU, China, June 20, 2018 /PRNewswire/ — Chinese bio-pharmaceutical developer, manufacturer and marketer of oncology drugs…